HopeStage
Back to all studies
Active Not RecruitingNCT07199179

Psychological pain and loss of pleasure during add-on esketamine for suicidal thoughts

About this titleRead the official source — NCT07199179
Observational studyAges 18–64FranceDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 64 years.

Listed locations
MontpellierSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 24, 2024
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
456
Sponsor
University Hospital, Montpellier
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
France
Age range
From 18 Years to 64 Years
Official registry ID
NCT07199179
Official title
Show the full official title

Link Between Reduction of Suicide Ideation by Esketamine in Add-On and Initial Levels of Psychological Pain and Anhedonia

Recruitment & locations

Not recruiting

Montpellier

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Hospital, Montpellier, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 64 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies